Cite
HARVARD Citation
Ikumi, K. et al. (2022). Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients. Journal of dermatology. 49 (4), pp. e125-e126. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ikumi, K. et al. (2022). Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients. Journal of dermatology. 49 (4), pp. e125-e126. [Online].